Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab

Annals of Surgical Oncology

Volumn 16, Issue 6, 2009, Pages 1553-1559

  Aussilhou, Béatrice ^a   Dokmak, Safi ^a   Faivre, Sandrine ^a   Paradis, Valérie ^a   Vilgrain, Valérie ^a   Belghiti, Jacques ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BEVACIZUMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGE; AGED; ARTICLE; BILE LEAKAGE; CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; EVALUATION; FEMALE; FEVER; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; KIDNEY FAILURE; LIVER FAILURE; LIVER FIBROSIS; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER REGENERATION; LIVER RESECTION; LIVER SINUSOID; LIVER SINUSOIDAL DILATATION; LIVER SIZE; LIVER TOXICITY; LUNG COMPLICATION; MALE; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; PORTAL VEIN OBSTRUCTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; STEATOSIS; SURGICAL RISK; TREATMENT RESPONSE;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; HYPERTROPHY; LEUCOVORIN; LIGATION; LIVER; LIVER CIRCULATION; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PORTAL VEIN; PREOPERATIVE CARE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67349095615     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0447-z     Document Type: Article

References (29)

1. M Karoui C Penna M Amin-Hashem 2006 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 1 7 (Pubitemid 43054046)
2. D Zorzi A Laurent TM Pawlik GY Lauwers JN Vauthey EK Abdalla 2007 Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 94 274 286 (Pubitemid 46423843)
3. S Ogata J Belghiti O Farges D Varma A Siber V Vilgrain 2006 Sequential arterial and portal vein embolization before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma Br J Surg 93 1091 1098 (Pubitemid 44343506)
4. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucoverin for metastatic colorectal cancer N Engl J Med 350 2335 2342 (Pubitemid 38702844)
5. LB Saltz S Clarke E Díaz-Rubio 2008 Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 2013 2019
6. TR Howdieshell D Callaway WL Webb 2001 Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation J Surg Res 96 173 182
7. M D'angelica P Kornprat M Gonen 2007 Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study Ann Surg Oncol 14 759 765 (Pubitemid 46175324)
8. D Zorzi YS Chun DC Madoff EK Abdalla JN Vauthey 2008 Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases Ann Surg Oncol 15 2765 2772
9. SK Reddy MA Morse HI Hurwitz 2008 Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases J Am Coll Surg 206 96 106 (Pubitemid 350267242)
10. G Van Buren A Yang N Dallas 2008 The effect of molecular therapeutics on liver regeneration in a murine model J Clin Oncol 26 1836 1842
11. CA Redaelli D Semela FE Carrick 2004 Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice J Hepatol 40 305 312 (Pubitemid 38115837)
12. Dokmak S, Aussilhou B, Faivre S, et al. Hépatectomie pour métastases hépatiques de cancer colorectal après chimiothérapie associée au bevacizumab: série unicentrique de 23 malades (abstract). J Chir. 2007;144.
13. O Farges J Belghiti R Kianmanesh 2003 Portal vein embolization before right hepatectomy: prospective clinical trial Ann Surg 237 208 217 (Pubitemid 38173248)
14. S Balzan J Belghiti O Farges A Sauvanet 2005 The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy Ann Surg 242 824 828 (Pubitemid 41714060)
15. F Zhang MP Lei TM Oswald 2003 The effect of vascular endothelial growth factor on the healing of ischemic skin wounds Br J Plast Surg 56 334 341 (Pubitemid 36927265)
16. Giantonio BJ, Catalano PJ, Meropol NJ, et al. High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG) study E3200. J Clin Oncol. 2005;23:16s.
17. CD Roman H Choy L Nanney 2002 Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats J Surg Res 105 43 47 (Pubitemid 34713210)
18. J LeCouter DR Moritz B Li 2003 Angiogenesis-independant endothelial protection of liver: role of VEGFR-1 Science 299 890 893 (Pubitemid 36182447)
19. D Ribero EK Abdalla DC Madoff 2007 Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome Br J Surg 94 1386 1394 (Pubitemid 350144388)
20. DR Di Stefano T de Baere A Denys 2005 Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients Radiology 234 625 630 (Pubitemid 40139940)
21. B Aussilhou M Lesurtel A Sauvanet 2008 Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant J Gastrointest Surg 12 297 303
22. T Aloia M Sebagh M Plasse 2006 Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 4983 4990 (Pubitemid 46631400)
23. D Ribero H Wang M Donadon 2007 Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer 110 2761 2767 (Pubitemid 350250347)
24. L Rubba-Brandt E Giostra C Brezault 2007 Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by liver surgery Ann Oncol 18 299 304 (Pubitemid 46323097)
25. B Gruenberger D Tamandl J Schueller 2008 Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 1830 1835
26. EK Abdalla SA Curley JN Vauthey 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 818 827 (Pubitemid 38669432)
27. H Bismuth R Adam F Levi 2000 Resection of unresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 66 611 615
28. R Adam V Delvart G Pasal 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644 657 (Pubitemid 39281287)
29. N Gagliano F Grizzi G Annoni 2007 Mechanisms of aging and liver functions Dig Dis 25 118 123 (Pubitemid 46663777)